The present invention provides a compound represented by the formula [structure] which is useful as an agent for the prophylaxis or treatment of diseases related to the action of melatonin, or a salt thereof and the like.

Claims

3 · 3 independent · depth 1

3 granted claims

›1.independent(S)-N-[2-(2-Methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]thiazol-8-yl)ethyl]acetamide, or a pharmaceutically acceptable salt thereof.

›2.independentA method for treating a sleep disorder in a mammal, comprising administering an effective amount of (S)-N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,…

›3.independentA method for treating depression, anxiety or bipolar disorder in a mammal, comprising administering an effective amount of (S)-N-[2-(2-methyl-7,8-dihy…

Classifications

4 codes

IPC · International Patent Classification

Section A — Human necessities

A61K31/428

Section C — Chemistry; metallurgy

C07D277/60

USPC · US Patent Classification

514/366548/150

Claim changes

Soon

Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom

USPTOApplicanthover for detail · click to open

Pendency

1.7 y

624 days filing → grant

Office actions

none on record

Responses

no RCE

Examiner

Matthew Coughlin

art unit —

Law firm

Law firm · Log in to unlock

Citations: 46 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Priority chain

1 priority documents

›Priority documents — 1

Type	Document	Date
related publication	US 20110196003 A1	11 Aug 2011

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.